Sangamo Therapeutics, Inc. Profile Avatar - Palmy Investing

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The…

Biotechnology
US, Brisbane California [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Sangamo Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Sangamo Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Sangamo Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of SGMO's Analysis
CIK: 1001233 CUSIP: 800677106 ISIN: US8006771062 LEI: - UEI: -
Secondary Listings